AU6149600A - Novel vector complexes and their use in gene therapy - Google Patents

Novel vector complexes and their use in gene therapy

Info

Publication number
AU6149600A
AU6149600A AU61496/00A AU6149600A AU6149600A AU 6149600 A AU6149600 A AU 6149600A AU 61496/00 A AU61496/00 A AU 61496/00A AU 6149600 A AU6149600 A AU 6149600A AU 6149600 A AU6149600 A AU 6149600A
Authority
AU
Australia
Prior art keywords
gene therapy
novel vector
vector complexes
complexes
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61496/00A
Inventor
Sabine Brusselbach
Thomas Kissel
Rolf Muller
Hans-Harald Sedlacek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Publication of AU6149600A publication Critical patent/AU6149600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU61496/00A 1999-06-24 2000-06-10 Novel vector complexes and their use in gene therapy Abandoned AU6149600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19929104 1999-06-24
DE1999129104 DE19929104A1 (en) 1999-06-24 1999-06-24 Vector complex, useful for gene therapy of e.g. tumors, comprises nucleic acid, cationic carrier, charged polymer and targeting ligand
PCT/EP2000/005371 WO2001000241A2 (en) 1999-06-24 2000-06-10 Novel vector complexes and their use in gene therapy

Publications (1)

Publication Number Publication Date
AU6149600A true AU6149600A (en) 2001-01-31

Family

ID=7912489

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61496/00A Abandoned AU6149600A (en) 1999-06-24 2000-06-10 Novel vector complexes and their use in gene therapy

Country Status (5)

Country Link
EP (1) EP1196618A2 (en)
JP (1) JP2003503362A (en)
AU (1) AU6149600A (en)
DE (1) DE19929104A1 (en)
WO (1) WO2001000241A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1711074B (en) * 2002-11-15 2010-10-06 尼普洛株式会社 Liposomes
JP2005298486A (en) * 2004-03-15 2005-10-27 Nipro Corp Liposome-containing medicinal composition for treating cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4119590A (en) * 1975-05-22 1978-10-10 Toyo Soda Manufacturing Co., Ltd. Process for producing a polyion complex having a nucleic acid base
US4847240A (en) * 1978-01-16 1989-07-11 The Trustees Of Boston University Method of effecting cellular uptake of molecules
US5354844A (en) * 1989-03-16 1994-10-11 Boehringer Ingelheim International Gmbh Protein-polycation conjugates
US5574142A (en) * 1992-12-15 1996-11-12 Microprobe Corporation Peptide linkers for improved oligonucleotide delivery
US5908777A (en) * 1995-06-23 1999-06-01 University Of Pittsburgh Lipidic vector for nucleic acid delivery
FR2739292B1 (en) * 1995-09-28 1997-10-31 Rhone Poulenc Rorer Sa PHARMACEUTICAL COMPOSITION USEFUL FOR TRANSFECTING NUCLEIC ACIDS AND USES THEREOF
DE19605279A1 (en) * 1996-02-13 1997-08-14 Hoechst Ag Target cell-specific vectors for the introduction of genes into cells, drugs containing such vectors and their use
JP2000514440A (en) * 1996-07-09 2000-10-31 ザ ジョーンズ ホプキンス ユニバーシティー Gene transfer system
US5948681A (en) * 1996-08-14 1999-09-07 Children's Hospital Of Philadelphia Non-viral vehicles for use in gene transfer
GB9623051D0 (en) * 1996-11-06 1997-01-08 Schacht Etienne H Delivery of DNA to target cells in biological systems
DE19649645A1 (en) * 1996-11-29 1998-06-04 Hoechst Ag Multiple functional ligand system for target cell-specific transfer of nucleotide sequences

Also Published As

Publication number Publication date
WO2001000241A2 (en) 2001-01-04
WO2001000241A3 (en) 2001-08-09
EP1196618A2 (en) 2002-04-17
DE19929104A1 (en) 2000-12-28
JP2003503362A (en) 2003-01-28

Similar Documents

Publication Publication Date Title
IL231294A0 (en) Genetic products differentially expressed in tumors and the use thereof
IL244596A0 (en) Genetic products differentially expressed in tumors and use thereof
AU3869400A (en) Human cancer associated gene sequences and polypeptides
AU3316600A (en) Gene expression in bladder tumors
AU4289100A (en) Dihydropyrimidines and their use in the treatment of hepatitis
AU715620C (en) Therapeutic methods and uses
AU1164601A (en) Therapeutic use and formulation
AU7058000A (en) 13 human colon and colon cancer associated proteins
AU1598599A (en) Anti-angiogenic gene therapy vectors and their use in treating angiogenesis-related diseases
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AU6149600A (en) Novel vector complexes and their use in gene therapy
AU4328399A (en) Nucleic acid-cobalamin complexes and their use in gene therapy
AU2400401A (en) Novel phosphodiesterases and genes thereof
AU1894601A (en) Novel gene and use thereof
AU1576501A (en) Methods to enhance and confine gene expression in cancer therapy
AU5871898A (en) Microparticles and their use in cancer treatment
AU5617200A (en) Nodavirus-based dna expression vector and uses thereof
AU5217100A (en) Adenoviral vectors encoding interferon and their use in gene therapy
AU8282498A (en) A senescence gene and its use in the treatment of cancer and other diseases
AU2002319200A1 (en) Vector and the use thereof in gene therapy methods
AU5760200A (en) Human genes and proteins encoded thereby
AU5309500A (en) Novel human genes and proteins encoded thereby
AU5996100A (en) Triplex-forming oligonucleotides and their use in therapy
AU3698699A (en) Vectors and viruses used in gene therapy
AU2003203787A1 (en) Differentially Expressed Genes in Cardiac Hypertrophy and their uses in Treatment and Diagnosis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase